Showing results (61-70 of 223) with videos related to
Sort By:
Pageof 23
Sexually Transmitted Infections|July 4, 2024
B/F/TAF forgiveness to non-adherenceFranco Maggiolo, Lucia Taramasso, Daniela Valenti, et al.Journal of Travel Medicine|November 13, 2007
Eosinophilic meningitis in a returned traveler from Santo Domingo: case report and reviewSebastiano Leone, Michele De Marco, Piero Ghirga, et al.BMC Infectious Diseases|October 12, 2022
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patientsFranco Maggiolo, Roberto Gulminetti, Layla Pagnucco, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Outcome of 2 simplification strategies for the treatment of human immunodeficiency virus type 1 infectionFranco Maggiolo, Diego Ripamonti, Laura Ravasio, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2004
Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitorsFranco Maggiolo, Laura Ravasio, Diego Ripamonti, et al.Journal of the International AIDS Society|November 15, 2014
Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health statusFranco Maggiolo, Sergio Di Matteo, Giacomo Bruno, et al.AIDS (London, England)|November 21, 2007
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transferDiego Ripamonti, Dario Cattaneo, Franco Maggiolo, et al.Journal of Medical Virology|July 25, 2020
SARS-CoV-2 infection in persons living with HIV: A single center prospective cohortFranco Maggiolo, Fabio Zoboli, Marco Arosio, et al.Antiviral Therapy|October 2, 2003
Once-a-day therapy for HIV infection: a controlled, randomized study in antiretroviral-naive HIV-1-infected patientsFranco Maggiolo, Diego Ripamonti, Gianpietro Gregis, et al.Le Infezioni in Medicina|May 20, 2003
[Outpatient parenteral antibiotic therapy (OPAT) of diabetic foot infections with piperacillin/tazobactam]Alberto Marvaso, Silvano Esposito, Silvana Noviello, et al.Pageof 23